Galaxy Digital Inc. Class A Common Stock vs TransMedics Group Inc — how do they compare? Galaxy Digital Inc. Class A Common Stock trades at $20.25 (market cap $3.90B), while TransMedics Group Inc trades at $77.62 (market cap $2.74B). The key difference: Galaxy Digital Inc. Class A Common Stock is the larger of the two by market cap, and TransMedics Group Inc is more actively traded (949,331 versus 7,887,173). Which is the better fit depends on your goals — on Pluang, investors hold Galaxy Digital Inc. Class A Common Stock for 0 Days and TransMedics Group Inc for 24 Days on average.
| GLXY | TMDX | |
|---|---|---|
Market Cap | $3.90B | $2.74B |
Volume | 7,887,173 | 949,331 |
Sector | Financials | Health |
52-Week High | $42.86 | $150.42 |
52-Week Low | $16.84 | $61.99 |
Typical Hold Time | 0 Days | 24 Days |
Enterprise Value | $6.36B | $3.13B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
TransMedics Group (TMDX) trades at $80.69, down 0.47% on the day, amid a bearish technical signal and mixed earnings performance. The company reported strong revenue growth to $605.49M in 2025 with a net income margin of 22.69%, but recent quarters have seen earnings misses. Analyst sentiment remains positive with a consensus price target of $99.75 and a 69% buy rating, though news flow includes investigations into fiduciary duties.
The outlook balances robust fundamentals against near-term headwinds. Upside potential exists from the high analyst target and strong profitability metrics like a 36.28% ROE, but risks include earnings volatility, margin pressure, and ongoing legal scrutiny. The stock's current valuation at a P/E of 20.47 offers a reasonable entry if execution improves.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Galaxy provides digital-asset financial services and data center infrastructure. Its digital-assets business includes trading, asset management, investment banking, staking, tokenization, and custody technology.
Read more on GLXY →TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →